CNS melanocortin system involvement in the regulation of food intake

Hormones and Behavior

Volumn 37, Issue 4, 2000, Pages 299-305

  Benoit, Stephen ^a   Schwartz, Michael ^b   Baskin, Denis ^b   Woods, Stephen C ^a   Seeley, Randy J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; DISEASE ASSOCIATION; ENERGY BALANCE; FOOD INTAKE; GENE DELETION; GENE MUTATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033938492     PISSN: 0018506X     EISSN: None     Source Type: Journal    
DOI: 10.1006/hbeh.2000.1588     Document Type: Article

References (61)

1. Baskin D. G., Breininger J. F., Schwartz M. W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 48:1999a;828-833.
2. Baskin D. G., Schwartz M. W., Seeley R. J., Woods S. C., Porte D. J., Breininger J. F., Yonak Z., Schaefer J., Krouse M., Burghardt C., Campfield L. A., Burn P., Kochan J. P. Leptin receptor long form splice variant protein expression in neuron cell bodies of the brain and colocalization with neuropeptide Y mRNA in the arcuate nucleus. J. Histochem. Cytochem. 47:1999b;353-362.
3. Baskin D. G., Seeley R. J., Kuijper J. L., Lok S., Weigle D. S., Erickson J. C., Palmiter R. D., Schwartz M. W. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes. 47:1998;538-543.
4. Benoit, S. C, Schwartz, M. W, Lachey, J. L, Hagan, M. M, Rushing, P. A, Yagaloff, K, Grazyna, K, Franco, L, Danhoo, W, and, Seeley, R. J. (submitted), A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J. Neurosci.
5. Bergendahl M., Wiemann J. N., Clifton D. K., Huhtaniemi I., Steiner R. A. Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinol. 56:1992;913-920.
6. Boston B., Blaydon K., Varnerin J., Cone R. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science. 278:1997;1641-1644.
7. Boston B., Cone R. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology. 137:1996;2043-2050.
8. Broberger C., Johansen J., Johansson C., Schalling M., Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Nat. Acad. Sci. USA. 95:1998;15043-15048.
9. Bultman S., Michaud E., Woychik R. Molecular characterization of the mouse agouti locus. Cell. 71:1992;1195-1204.
10. Campfield L. A., Smith F. J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:1995;546-549.
11. Cheung C. C., Clifton D. K., Steiner R. A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 138:1997;4489-4492.
12. Clark J. T., Kalra P. S., Crowley W. R., Kalra S. P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
13. Cone R. D., Lu D., Koppula S., Vage D. I., Klungland H., Boston B., Chen W., Orth D. N., Pouton C., Kesterson R. A. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Rec. Prog. Horm. Res. 51:1996;287-320.
14. Considine R. V., Sinha M. K., Heiman M. L., Kriaucinas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., McKee L. J., Bauer T. L., Caro J. F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl. J. Med. 334:1996;292-295.
15. Delbende C., Jegou S., Leroux P., Tonon M., Mocaer E., Pelletier G., Vaudry H. [Role of alpha-MSH and related peptides in the central nervous system]. Rev. Neurol. 141:1985;429-439.
16. Elmquist J. K., Ahima R. S., Maratos-Flier E., Flier J. S., Saper C. B. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology. 138:1997;839-842.
17. Fan W., Boston B., Kesterson R., Hruby V., Cone R. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
18. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268:1993;15174-15179.
19. Grill H. J., Ginsberg A. B., Seeley R. J., Kaplan J. M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18:1998;10128-10135.
20. Hagan M., Rushing P., Schwartz M., Yagaloff K., Burn P., Woods S., Seeley R. Role of the CNS melanocortin system in the response to overfeeding. J. Neurosci. 19:1999;2362-2367.
21. Hagan, M. M, Rushing, P. A, Pritchard, L. M, Schwartz, M. W, Strack, A, Van der Ploeg, L, Woods, S. C, and, Seeley, R. J. (accepted), Long-term orexigenic effects of agouti related peptide (83-132) involve mechanisms other than melanocortin receptor blockade, Am. J. Physiol.
22. Hahn T. M., Breininger J. F., Baskin D. G., Schwartz M. W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1:1998;271-272.
23. Halaas J. L., Boozer C., Blair-West J., Fidahusein N., Denton D. A., Friedman J. M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Nat. Acad. Sci. USA. 94:1997;8878-8883.
24. Halaas J. L., Gajiwala K. S., Maffel M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
25. Harrold J., Widdowson P., Williams G. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: Further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes. 48:1999;267-271.
26. Hinney A., Schmidt A., Nottebom K., Heibult O., Becker I., Ziegler A., Gerber G., Sina M., Gorg T., Mayer H., Siegfried W., Fichter M., Remschmidt H., Hebebrand J. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 84:1999;1483-1486.
27. Huszar D., Lynch C., Dunmore J., Fang Q., Berkemeier L., Gu W., Kesterson R., Boston B., Cone R., Smith F., Campfield L., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
28. Jackson I. Homologous pigmentation mutations in human, mouse and other model organisms. Hum. Mol. Genet. 6:1997;1613-1624.
29. Kask A., Mutulis F., Muceniece R., Pahkla R., Mutule I., Wikberg J., Rago L., Schioth H. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo. Endocrinology. 139:1998;5006-5014.
30. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19:1998;155-157.
31. Lu D., Willard D., Patel I., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R., Wilkison W. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 371:1994;799-802.
32. Marsh D., Hollopeter G., Huszar D., Laufer R., Yagaloff K., Fisher S., Burn P., Palmiter R. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21:1999;119-122.
33. Marsh D., Miura G., Yagaloff K., Schwartz M., Barsh G., Palmiter R. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res. 848:1999;66-77.
34. McMinn J. E., Seeley R. J., Wilkinson C. W., Havel P. J., Woods S. C., Schwartz M. W. NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: Potential roles of plasma insulin and leptin. Regul. Pept. 75-76:1998;425-431.
35. Miller M., Duhl D., Vrieling H., Cordes S., Ollmann M., Winkes B., Barsh G. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7:1993;454-467.
36. Mizuno T., Kleopoulos S., Bergen H., Roberts J., Priest C., Mobbs C. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin. Diabetes. 47:1998;294-297.
37. Mountjoy K., Mortrud M., Low M., Simerly R., Cone R. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
38. Mountjoy K., Robbins L., Mortrud M., Cone R. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
39. Mountjoy K., Wong J. Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol. Cell. Endocrinol. 128:1997;171-177.
40. Ollmann M., Wilson B., Yang Y., Kerns J., Chen Y., Gantz I., Barsh G. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-138.
41. Pelleymounter M. A., Cullen M. J., Baker M. B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:1995;540-543.
42. Roselli-Rehfuss L., Mountjoy K., Robbins L., Mortrud M., Low M., Tatro J., Entwistle M., Simerly R., Cone R. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Nat. Acad. Sci. USA. 90:1993;8856-8860.
43. Rossi M., Kim M., Morgan D., Small C., Edwards C., Sunter D., Abusnana S., Goldstone A., Russell S., Stanley S., Smith D., Yagaloff K., Ghatei M., Bloom S. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology. 139:1998;4428-4431.
44. Satoh N., Ogawa Y., Katsuura G., Numata Y., Masuzaki H., Yoshimasa Y., Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neuroscience Lett. 249:1998;107-110.
45. Schioth H., Chhajlani V., Muceniece R., Klusa V., Wikberg J. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sci. 59:1996;797-801.
46. Schioth H., Muceniece R., Larsson M., Wikberg J. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH. J. Endocrinol. 155:1997;73-78.
47. Schwartz M. W., Peskind E., Raskind M., Nicolson M., Moore J., Morawiecki A., Boyko E. J., Porte D. J. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat. Med. 2:1996;589-593.
48. Schwartz M. W., Seeley R. J. Neuroendocrine responses to starvation and weight loss. New Engl. J. Med. 336:1997;1802-1811.
49. Schwartz M. W., Seeley R. J., Weigle D. S., Burn P., Campfield L. A., Baskin D. G. Leptin increases hypothalamic proopiomelanocoritin (POMC) mRNA expression in the rostral arcuate nucleus. Diabetes. 46:1997;2119-2123.
50. Seeley R., Yagaloff K., Fisher S., Burn P., Thiele T., van D. G., Baskin D., Schwartz M. Melanocortin receptors in leptin effects. Nature. 390:1997;349.
51. Seeley R. J., van Dijk G., Campfield L. A., Smith F. J., Nelligan J. A., Bell S. M., Baskin D. G., Woods S. C., Schwartz M. W. The effect of intraventricular administration of leptin on food intake and body weight in the rat. Horm. Metab. Res. 28:1996;664-668.
52. Shimizu H., Shargill N., Bray G., Yen T., Gesellchen P. Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. Life Sci. 45:1989;543-552.
53. Shutter J., Graham M., Kinsey A., Scully S., Luthy R., Stark K. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11:1997;593-602.
54. Tatro J. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation. 3:1996;259-284.
55. Thiele T., van D. G., Yagaloff K., Fisher S., Schwartz M., Burn P., Seeley R. Central infusion of melanocortin agonist MTII in rats: Assessment of c-Fos expression and taste aversion. Am. J. Physiol. 274:1998;R248-R254.
56. Thornton J. E., Cheung C. C., Clifton D. K., Steiner R. A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology. 138:1997;5063-5067.
57. Vaisse C., Clement K., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20:1998;113-114.
58. van Dijk G., Seeley R. J., Thiele T. E., Friedman M. I., Ji H., Wilkinson C. W., Burn P., Campfield L. A., Tenenbaum R., Baskin D. G., Woods S. C., Schwartz M. W. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat. Am. J. Physiol. 276:1999;R1425-R1433.
59. Wilson B., Bagnol D., Kaelin C., Ollmann M., Gantz I., Watson S., Barsh G. Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology. 140:1999;2387-2397.
60. Xue B., Moustaid-N., Wilkison W., Zemel M. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J. 12:1998;1391-1396.
61. Yeo G., Farooqi I., Aminian S., Halsall D., Stanhope R., O' Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20:1998;111-112.